Literature DB >> 9004140

Rapid diagnostic test for the major mutation underlying Batten disease.

I Järvelä1, H M Mitchison, P B Munroe, A M O'Rawe, S E Mole, A C Syvänen.   

Abstract

Batten disease is the most common progressive neurodegenerative disorder of childhood in western countries. A novel cDNA responsible for Batten disease has recently been identified. We have developed a rapid diagnostic solid phase minisequencing test to detect the major 1.02 kb deletion which is responsible for 81% of affected chromosomes in Batten disease worldwide. In Finland, 90% of Batten chromosomes carry the major deletion owing to the enrichment of the CLN3 gene in the isolated Finnish population.

Entities:  

Mesh:

Year:  1996        PMID: 9004140      PMCID: PMC1050819          DOI: 10.1136/jmg.33.12.1041

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  6 in total

1.  Preferential PCR amplification of alleles: mechanisms and solutions.

Authors:  P S Walsh; H A Erlich; R Higuchi
Journal:  PCR Methods Appl       Date:  1992-05

2.  Batten disease (Spielmeyer-Vogt disease, juvenile onset neuronal ceroid-lipofuscinosis) gene (CLN3) maps to human chromosome 16.

Authors:  M Gardiner; A Sandford; M Deadman; J Poulton; W Cookson; S Reeders; I Jokiaho; L Peltonen; H Eiberg; C Julier
Journal:  Genomics       Date:  1990-10       Impact factor: 5.736

3.  Convenient and quantitative determination of the frequency of a mutant allele using solid-phase minisequencing: application to aspartylglucosaminuria in Finland.

Authors:  A C Syvänen; E Ikonen; T Manninen; M Bengtström; H Söderlund; P Aula; L Peltonen
Journal:  Genomics       Date:  1992-03       Impact factor: 5.736

Review 4.  Neuronal ceroid-lipofuscinoses in childhood.

Authors:  P Santavuori
Journal:  Brain Dev       Date:  1988       Impact factor: 1.961

5.  Prenatal diagnosis of Batten's disease.

Authors:  P B Munroe; J Rapola; H M Mitchison; A Mustonen; S E Mole; R M Gardiner; I Jarvela
Journal:  Lancet       Date:  1996-04-13       Impact factor: 79.321

6.  Batten disease gene, CLN3: linkage disequilibrium mapping in the Finnish population, and analysis of European haplotypes.

Authors:  H M Mitchison; A M O'Rawe; P E Taschner; L A Sandkuijl; P Santavuori; N de Vos; M H Breuning; S E Mole; R M Gardiner; I E Järvelä
Journal:  Am J Hum Genet       Date:  1995-03       Impact factor: 11.025

  6 in total
  7 in total

Review 1.  The Finnish Disease Heritage III: the individual diseases.

Authors:  Reijo Norio
Journal:  Hum Genet       Date:  2003-03-08       Impact factor: 4.132

2.  Homogeneous polymerase chain reaction nucleobase quenching assay to detect the 1-kbp deletion in CLN3 that causes Batten disease.

Authors:  Paul G Rothberg; Denia Ramirez-Montealegre; Sharon D Frazier; David A Pearce
Journal:  J Mol Diagn       Date:  2004-08       Impact factor: 5.568

3.  [18F]fluorodopa PET shows striatal dopaminergic dysfunction in juvenile neuronal ceroid lipofuscinosis.

Authors:  H M Ruottinen; J O Rinne; M Haaparanta; O Solin; J Bergman; V J Oikonen; I Järvelä; P Santavuori
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-06       Impact factor: 10.154

4.  Rapid detection of the major deletion in the Batten disease gene CLN3 by allele specific PCR.

Authors:  P E Taschner; N de Vos; M H Breuning
Journal:  J Med Genet       Date:  1997-11       Impact factor: 6.318

5.  A diagnostic confidence scheme for CLN3 disease.

Authors:  Margaux C Masten; Camille Corre; Alex R Paciorkowski; Amy Vierhile; Heather R Adams; Jennifer Vermilion; Grace A Zimmerman; Erika F Augustine; Jonathan W Mink
Journal:  J Inherit Metab Dis       Date:  2021-09-07       Impact factor: 4.750

6.  A human model of Batten disease shows role of CLN3 in phagocytosis at the photoreceptor-RPE interface.

Authors:  Cynthia Tang; Jimin Han; Sonal Dalvi; Kannan Manian; Lauren Winschel; Stefanie Volland; Celia A Soto; Chad A Galloway; Whitney Spencer; Michael Roll; Caroline Milliner; Vera L Bonilha; Tyler B Johnson; Lisa Latchney; Jill M Weimer; Erika F Augustine; Jonathan W Mink; Vamsi K Gullapalli; Mina Chung; David S Williams; Ruchira Singh
Journal:  Commun Biol       Date:  2021-02-05

7.  Autophagic vacuolar myopathy is a common feature of CLN3 disease.

Authors:  Josefine Radke; Randi Koll; Esther Gill; Lars Wiese; Angela Schulz; Alfried Kohlschütter; Markus Schuelke; Christian Hagel; Werner Stenzel; Hans H Goebel
Journal:  Ann Clin Transl Neurol       Date:  2018-10-14       Impact factor: 4.511

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.